Skip to main content
. 2024 Nov 8;11(12):ofae650. doi: 10.1093/ofid/ofae650

Figure 1.

Figure 1.

Prevalence of T. cruzi serology in a cohort of solid organ transplant recipients from 2019 to 2023. (A–D) describe the prevalence of T. cruzi by year of screening, ethnicity, sex and transplanted organ. a2023 lung vs heart P = .004; lung vs liver P = .005; lung vs kidney P = .002; 2022 lung vs heart P = .004; lung vs liver P = .005; lung vs kidney P = .001. b2023 heart vs kidney P = .021; 2022 heart vs kidney P = .021; 2021 heart vs kidney P = .021 and 2019 heart vs kidney P = .003. c2019 liver vs kidney P = .003. dP < .0001. eP = .043.